Dow Up0.11% Nasdaq Up0.50%

Meridian Bioscience, Inc. (VIVO)

-NasdaqGS
19.57 Down 0.06(0.31%) Aug 29, 4:00PM EDT
|After Hours : 19.57 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 47,212   50,134   44,794   48,962  
Cost of Revenue17,970  18,541  16,787  18,088  
Gross Profit 29,242   31,593   28,007   30,874  
Operating Expenses
Research Development3,146  3,186  2,853  2,748  
Selling General and Administrative12,964  12,741  13,528  14,855  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 13,132   15,666   11,626   13,271  
Income from Continuing Operations
Total Other Income/Expenses Net(252)(22)(216)(215)
Earnings Before Interest And Taxes12,880  15,644  11,410  13,056  
Interest Expense -   -   -   -  
Income Before Tax12,880  15,644  11,410  13,056  
Income Tax Expense4,045  5,344  3,984  3,906  
Minority Interest -   -   -   -  
Net Income From Continuing Ops8,835  10,300  7,426  9,150  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 8,835   10,300   7,426   9,150  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 8,835   10,300   7,426   9,150  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.